Can high altitude influence cytokines and sleep?

Area of Science:

• Physiology
• Sleep Science
• Altitude Medicine

Background:

• Increasing global travel and migration to high-altitude regions necessitate understanding physiological adaptations.
• Hypoxia at high altitudes presents metabolic challenges, impacting various bodily functions, including sleep quality.
• Sleep fragmentation is a recognized consequence of high-altitude exposure, contributing to adverse health effects.

Purpose of the Study:

• To review literature from 1987-2012 on the interplay of inflammation, hypoxia, and sleep during altitude adaptation.
• To explore the relationship between altitude-induced hypoxia and sleep disturbances.
• To investigate a novel mechanism involving inflammatory cytokines in altitude's negative impact on sleep.

Main Methods:

• Literature review conducted for studies published between 1987 and 2012.
• Analysis focused on research examining physiological responses to high altitude.
• Exploration of cytokine production (IL-1 β, IL-6, TNF- α) in relation to hypoxia and sleep.

Main Results:

• High altitude exposure is linked to increased production of inflammatory cytokines, including Interleukin-1 beta (IL-1 β), Interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF- α).
• These cytokines originate from various tissues and cells, such as leukocytes, skeletal muscle, and brain cells.
• Elevated cytokine levels are implicated as a potential mechanism contributing to sleep disturbances at high altitudes.

Conclusions:

• Inflammation, driven by cytokines like IL-1 β, IL-6, and TNF- α, plays a significant role in sleep disruption at high altitudes.
• Understanding this inflammatory pathway offers insights into the adverse effects of altitude on sleep quality.
• Further research into cytokine modulation may provide strategies to mitigate sleep problems associated with high-altitude exposure.